Neogen (NEOG) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Neogen (NEOG) do?
Neogen Corp (NEOG) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures diagnostic test kits and genetic screening tools for food processors and farmers. Makes diagnostic test kits and genomic tools for food safety and animal health across agriculture supply chains. It is worth $2.37B on the market and sold $883.81M over the last year.
- Market cap
- $2.37B
- P/E ratio
- None (reported a loss)
- Annual sales
- $883.81M
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 17, 2026
Brands and businesses behind NEOG
- Petrifilm: Sells ready-to-use sample plates that culture and enumerate bacteria for commercial food safety testing.
- Igenity: Provides commercial genomic profiling tests for cattle producers to assess herd health, growth potential, and breeding traits.
- Reveal: Produces rapid lateral flow test strips that detect foodborne pathogens and allergens in food processing environments.
- Megazyme: Manufactures enzymatic assay kits and analytical reagents used in dietary fiber, carbohydrate, and beverage testing laboratories.
NEOG’s flags, in plain English
Each flag is a number from Neogen’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Stupid Cash
Can pay this year's bills 3.9 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 37% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Still Climbing
Sales up 13.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Burning Cash
Losing money, profit margin of -6.4%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
1 more green flag open with the free trial. Try it free for 7 days.
Questions about NEOG
How big is Neogen?
Neogen’s market cap is $2.37B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $883.81M: what customers paid the company over the last year, before any costs.
What is NEOG’s P/E ratio?
NEOG has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with NEOG?
The company carries substantial debt from acquiring 3M's food safety division while continuing to manage complex operational integration work. That is one risk on Neogen’s card. Its first risk flag is Burning Cash, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Neogen’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. NEOG’s filings on SEC.gov. The Margin Monkey is research, not advice.
